FROST PHILLIP MD 13D and 13G filings for Cocrystal Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 4:42 pm Purchase | 2025-10-28 | 13D | Cocrystal Pharma, Inc. COCP | FROST PHILLIP MD | 2,462,012 17.800% | 1,079,139 (+78.04%) | Filing |
| 2025-10-02 6:29 pm Purchase | 2025-09-30 | 13D | Cocrystal Pharma, Inc. COCP | FROST PHILLIP MD | 1,382,873 10.600% | 50,265 (+3.77%) | Filing |
| 2023-04-14 4:01 pm Purchase | 2023-04-04 | 13D | Cocrystal Pharma, Inc. COCP | FROST PHILLIP MD | 1,332,608 13.100% | 1,332,608 (New Position) | Filing |